Laboratory Workup for Generalized Paresthesia
For a patient presenting with paresthesia throughout the body, order the following initial laboratory panel: complete blood count, comprehensive metabolic panel (including glucose, electrolytes, kidney and liver function), HbA1c, vitamin B12, thyroid-stimulating hormone, and serum protein electrophoresis with immunofixation 1, 2.
Initial Essential Tests
The core screening battery should include:
- Complete blood count - to identify hematologic abnormalities
- Comprehensive metabolic panel - glucose, electrolytes, kidney function (BUN/creatinine), liver enzymes (AST/ALT) to exclude metabolic and electrolyte dysfunctions 3
- HbA1c - critical for detecting diabetes, which is the most common identifiable cause of peripheral neuropathy 2
- Vitamin B12 level - deficiency is a treatable cause, though found in only ~2% of cases 4
- Thyroid-stimulating hormone (TSH) - thyroid dysfunction can cause neuropathic symptoms 1, 2
- Serum protein electrophoresis with immunofixation - to screen for paraproteinemias and monoclonal gammopathies 2
Critical Consideration: Glucose Metabolism Testing
If initial fasting glucose and HbA1c are normal but clinical suspicion remains, strongly consider a 2-hour oral glucose tolerance test, as this has the highest diagnostic yield (61%) and is more sensitive than fasting glucose or HbA1c alone for detecting impaired glucose metabolism 4. This is particularly important because glucose dysregulation is the leading identifiable cause of sensory neuropathy.
Tests to Avoid Unless Specific Clinical Features Present
The following tests have low yield in generalized paresthesia without additional clinical indicators and should not be ordered routinely 1, 4:
- Antinuclear antibodies (ANA) - abnormal in <5% of patients, similar to general population rates
- Anti-ganglioside antibodies - limited diagnostic value unless Guillain-Barré syndrome is suspected 3
- Lyme serology, HIV testing, hepatitis panels - only if epidemiologic risk factors or systemic symptoms present
- Heavy metal screening - only with specific exposure history
- Genetic testing - reserve for cases with family history or specific hereditary patterns 1
When to Expand Testing
Additional investigations should be pursued only when 1:
- Basic screening is unrevealing
- Atypical features are present (rapid progression, motor weakness, asymmetry)
- Family history suggests hereditary neuropathy
- Specific systemic symptoms suggest autoimmune or infectious etiology
Common Pitfalls to Avoid
Do not order a "shotgun" panel of every possible test - this approach is inefficient, expensive, and leads to false-positive results that require unnecessary follow-up 1, 5. The abnormality rate for many specialized tests mirrors that of the general population when ordered indiscriminately 4.
Do not wait for all test results before considering referral - if the initial workup is negative and symptoms are progressive or disabling, refer to a neuromuscular specialist for electrodiagnostic studies and consideration of CSF examination or nerve biopsy 1, 2.
Clinical Context Matters
While the evidence focuses primarily on peripheral neuropathy workup, generalized paresthesia can have multiple etiologies. The laboratory approach should be guided by whether the pattern suggests:
- Peripheral neuropathy (stocking-glove distribution) - use the algorithm above
- Central nervous system pathology (non-dermatomal, associated with other CNS signs) - neuroimaging becomes priority
- Functional/psychogenic (non-anatomic, inconsistent) - basic metabolic screening only
The key principle is targeted testing based on clinical presentation rather than reflexive ordering of extensive panels 1, 5, 6.